HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nitza Lahat Selected Research

Nitza Lahat Research Topics

Disease

10Hypoxia (Hypoxemia)
10/2011 - 04/2002
4Ischemia
10/2011 - 08/2003
3Neoplasms (Cancer)
02/2016 - 11/2002
3Inflammation (Inflammations)
01/2012 - 08/2003
2Hyperoxia
01/2012 - 03/2009
2Infections
07/2008 - 01/2003
2Celiac Disease (Celiac Sprue)
10/2002 - 08/2002
1Pneumonia (Pneumonitis)
01/2012
1Bronchopulmonary Sequestration (Pulmonary Sequestration)
01/2012
1Leukopenia
01/2012
1Thrombocytopenia (Thrombopenia)
01/2012
1Sepsis (Septicemia)
01/2012
1Glaucoma
07/2011
1Blister (Bulla)
07/2011
1Renal Cell Carcinoma (Grawitz Tumor)
10/2010
1Heart Failure
03/2010
1Systolic Heart Failure
03/2010
1Reperfusion Injury
03/2009
1Ganglion Cysts (Ganglion)
05/2007
1Autoimmune Diseases (Autoimmune Disease)
11/2003
1Chronic Progressive Multiple Sclerosis
11/2003
1Viral Meningitis
01/2003
1Meningitis
01/2003
1Multiple Sclerosis
10/2002

Drug/Important Bio-Agent (IBA)

7Matrix Metalloproteinases (MMPs)IBA
02/2016 - 10/2002
6Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2012 - 08/2003
6Messenger RNA (mRNA)IBA
10/2011 - 04/2002
6Proteins (Proteins, Gene)FDA Link
10/2011 - 04/2002
5Tissue Inhibitor of Metalloproteinase-2IBA
07/2011 - 04/2002
4CytokinesIBA
03/2010 - 08/2003
3Oxygen (Dioxygen)IBA
01/2012 - 09/2003
3matrigelIBA
03/2011 - 11/2005
3Matrix Metalloproteinase 14 (MT1-MMP)IBA
11/2005 - 04/2002
2Interleukin-10 (Interleukin 10)IBA
10/2011 - 03/2010
2Tissue Inhibitor of Metalloproteinase-1IBA
07/2011 - 05/2007
2Transcription Factors (Transcription Factor)IBA
03/2011 - 01/2011
2Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
10/2010 - 09/2003
2LipopolysaccharidesIBA
07/2008 - 08/2003
2pro-matrix metalloproteinase 9IBA
05/2007 - 04/2006
2EnzymesIBA
09/2003 - 04/2002
2AntibodiesIBA
10/2002 - 08/2002
2Matrix Metalloproteinase 2 (Gelatinase A)IBA
10/2002 - 04/2002
2Protein Glutamine gamma Glutamyltransferase 2IBA
10/2002 - 08/2002
1Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))IBA
02/2016
1EpitopesIBA
02/2016
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2016
1L-SelectinIBA
01/2012
1HLA-DR Antigens (HLA-DR)IBA
10/2011
1AntigensIBA
10/2011
1Interleukin-2 (IL2)IBA
10/2011
1progelatinaseIBA
07/2011
1Mitomycin (Mitomycin-C)FDA LinkGeneric
07/2011
1Coloring Agents (Dyes)IBA
10/2010
1MicroRNAs (MicroRNA)IBA
10/2010
1Nitric Oxide (Nitrogen Monoxide)FDA Link
10/2010
1Free RadicalsIBA
03/2009
1Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
07/2008
1bafilomycin A1IBA
07/2008
1Nitric Oxide Synthase (NO Synthase)IBA
05/2007
1salicylhydroxamic acid (SHAM)IBA
05/2007
1Retinaldehyde (Retinal)IBA
05/2007
1Matrix Metalloproteinase InhibitorsIBA
05/2007
1Metalloproteases (Metalloproteinases)IBA
05/2007
1Minocycline (Cyclops)FDA LinkGeneric
05/2007
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
04/2006
1IntegrinsIBA
11/2005
1Peptide Hydrolases (Proteases)FDA Link
11/2005
1Integrin beta3 (GPIIIa)IBA
11/2005
1Interferon-betaIBA
11/2003
1ActininIBA
09/2003
1NitritesIBA
09/2003
1Interleukin-8 (Interleukin 8)IBA
01/2003
1Biomarkers (Surrogate Marker)IBA
01/2003
1InterleukinsIBA
01/2003
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
01/2003
1Intravenous Immunoglobulins (IVIG)FDA Link
11/2002
1gamma-Globulins (gamma-Globulin)IBA
11/2002
1InterferonsIBA
10/2002
1Interferon-gamma (Interferon, gamma)IBA
10/2002

Therapy/Procedure

2Therapeutics
02/2016 - 11/2003
1Ligation
01/2012
1Punctures
01/2012
1Filtering Surgery
07/2011
1Trabeculectomy (Trabeculoplasty)
07/2011